CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79.75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Spok Q3 net income more than triples on license sale

By Reuters News


Overview

  • US healthcare communications firm's Q3 revenue fell 2.6% yr/yr

  • Q3 net income rose over 200% yr/yr, boosted by gain on license sale

  • Adjusted EBITDA for Q3 rose nearly 30% yr/yr


Outlook

  • Spok reiterates 2026 full-year revenue guidance of $132.5 mln to $139.5 mln

  • Company expects 2026 adjusted EBITDA between $28 mln and $32 mln


Result Drivers

  • LICENSE SALE - Net income was boosted by gain on sale of narrowband spectrum licenses

  • SOFTWARE REVENUE MIX - Nearly 30% yr/yr growth in license revenue and more than 30% yr/yr increase in managed services revenue drove software revenue

  • OPERATING EXPENSES - Company reported a 7.3% yr/yr decrease in operating expenses, contributing to improved profitability


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Net Income

$9.72 mln

Q3 Adjusted EBITDA

$8.6 mln

Q3 Adjusted Operating Expenses

$26.06 mln

Q3 Operating Expenses

$27.36 mln

Q3 Revenue

$32.99 mln

Q3 Software Revenue

$16.01 mln


Reuters Recommended Reads

  • Oct 27 - HCA Healthcare Q3 revenue rises on admissions, emergency room visits growth

  • Oct 27 - NRC Health Q3 profit rises on recurring contract growth

  • Oct 27 - Ensign Group Q3 adjusted EPS beats estimates, revenue up on higher occupancy rates


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.